{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:09:32Z","timestamp":1792642172464,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11864-019-0672-z","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T07:02:48Z","timestamp":1565247768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Advanced Imaging Modalities to Monitor for Cardiotoxicity"],"prefix":"10.1007","volume":"20","author":[{"given":"Andreas","family":"Seraphim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Westwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish N.","family":"Bhuva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Crake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon J.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun K.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Slater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Oakervee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte H.","family":"Manisty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,8]]},"reference":[{"issue":"10","key":"672_CR1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2017.77.0446","volume":"36","author":"J Heymach","year":"2018","unstructured":"Heymach J, Krilov L, Alberg A, Baxter N, Chang SM, Corcoran RB, et al. Clinical Cancer Advances 2018: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol. 2018;36(10):1020\u201344.","journal-title":"J Clin Oncol"},{"issue":"23","key":"672_CR2","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","volume":"114","author":"D Cardinale","year":"2006","unstructured":"Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation. 2006;114(23):2474\u201381.","journal-title":"Circulation"},{"issue":"2","key":"672_CR3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.15420\/cfr.2017:16:1","volume":"3","author":"R Pudil","year":"2017","unstructured":"Pudil R. The future role of cardio-oncologists. Card Fail Rev. 2017;3(2):140\u20132.","journal-title":"Card Fail Rev"},{"issue":"4","key":"672_CR4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ihj.2017.05.006","volume":"69","author":"AK Ghosh","year":"2017","unstructured":"Ghosh AK, Walker JM. Cardio-oncology - a new subspecialty with collaboration at its heart. Indian Heart J. 2017;69(4):556\u201362.","journal-title":"Indian Heart J"},{"issue":"1","key":"672_CR5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","volume":"102","author":"A Albini","year":"2010","unstructured":"Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010;102(1):14\u201325.","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"672_CR6","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jacc.2010.07.023","volume":"56","author":"GJ Yoon","year":"2010","unstructured":"Yoon GJ, Telli ML, Kao DP, Matsuda KY, Carlson RW, Witteles RM. Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally? J Am Coll Cardiol. 2010;56(20):1644\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"672_CR7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bjc.2015.56","volume":"112","author":"P Savage","year":"2015","unstructured":"Savage P, Mahmoud S. Development and economic trends in cancer therapeutic drugs: a 5-year update 2010-2014. Br J Cancer. 2015;112(6):1037\u201341.","journal-title":"Br J Cancer"},{"issue":"6","key":"672_CR8","first-page":"941","volume":"62","author":"JW Kennedy","year":"1978","unstructured":"Kennedy JW, Sorensen SG, Ritchie JL, Folland ED, Hamilton GW. Radionuclide angiography for the evaluation of anthracycline therapy. Cancer Treat Rep. 1978;62(6):941\u20133.","journal-title":"Cancer Treat Rep"},{"issue":"Suppl 7","key":"672_CR9","doi-asserted-by":"crossref","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","volume":"23","author":"G Curigliano","year":"2012","unstructured":"\u2022\u2022 Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23(Suppl 7):vii155\u201366 Guidelines\/position statements from European Society of Medical Oncology (ESMO), European Society of Cardiology (ESC), American Society of Echocardiography (ASE), European Association of Cardiovascular Imaging (EACVI) and American Society of Clinical Oncology.","journal-title":"Ann Oncol"},{"issue":"36","key":"672_CR10","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"\u2022\u2022 Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768\u2013801 Guidelines\/position statements from European Society of Medical Oncology (ESMO), European Society of Cardiology (ESC), American Society of Echocardiography (ASE), European Association of Cardiovascular Imaging (EACVI) and American Society of Clinical Oncology.","journal-title":"Eur Heart J"},{"issue":"10","key":"672_CR11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","volume":"15","author":"JC Plana","year":"2014","unstructured":"\u2022\u2022 Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15(10):1063\u201393 Guidelines\/position statements from European Society of Medical Oncology (ESMO), European Society of Cardiology (ESC), American Society of Echocardiography (ASE), European Association of Cardiovascular Imaging (EACVI) and American Society of Clinical Oncology.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"672_CR12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"\u2022\u2022 Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(8):893\u2013911 Guidelines\/position statements from European Society of Medical Oncology (ESMO), European Society of Cardiology (ESC), American Society of Echocardiography (ASE), European Association of Cardiovascular Imaging (EACVI) and American Society of Clinical Oncology.","journal-title":"J Clin Oncol"},{"issue":"2","key":"672_CR13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdq609","volume":"22","author":"M Aapro","year":"2011","unstructured":"\u2022\u2022 Aapro M, Bernard-Marty C, Brain EGC, Batist G, Erdkamp F, Krzemieniecki K, et al. Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Ann Oncol. 2011;22(2):257\u201367 Guidelines\/position statements from European Society of Medical Oncology (ESMO), European Society of Cardiology (ESC), American Society of Echocardiography (ASE), European Association of Cardiovascular Imaging (EACVI) and American Society of Clinical Oncology.","journal-title":"Ann Oncol"},{"issue":"10","key":"672_CR14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.6004\/jnccn.2018.0078","volume":"16","author":"CS Denlinger","year":"2018","unstructured":"Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, et al. Survivorship, Version 2.2018. J Natl Compr Cancer Netw. 2018;16(10):1216\u201347.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"4 pt 1","key":"672_CR15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-94-4-430","volume":"94","author":"JS Gottdiener","year":"1981","unstructured":"Gottdiener JS, Mathisen DJ, Borer JS, Bonow RO, Myers CE, Barr LH, et al. Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography. Ann Intern Med. 1981;94(4 pt 1):430\u20135.","journal-title":"Ann Intern Med"},{"issue":"11","key":"672_CR16","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/sj.bjc.6600346","volume":"86","author":"T Nousiainen","year":"2002","unstructured":"Nousiainen T, Jantunen E, Vanninen E, Hartikainen J. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer. 2002;86(11):1697\u2013700.","journal-title":"Br J Cancer"},{"issue":"5","key":"672_CR17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/annonc\/mdf132","volume":"13","author":"BV Jensen","year":"2002","unstructured":"Jensen BV, Skovsgaard T, Nielsen SL. Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients. Ann Oncol. 2002;13(5):699\u2013709.","journal-title":"Ann Oncol"},{"issue":"2","key":"672_CR18","doi-asserted-by":"crossref","first-page":"e000774","DOI":"10.1136\/openhrt-2018-000774","volume":"5","author":"Robin Chung","year":"2018","unstructured":"Chung R, Ghosh AK, Banerjee A. Cardiotoxicity: precision medicine with imprecise definitions. Open Heart. 2018 [cited 2019 May 6];5(2). Available from: \n                      https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6074618\/\n                      \n                    .","journal-title":"Open Heart"},{"issue":"1","key":"672_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","volume":"61","author":"P Thavendiranathan","year":"2013","unstructured":"Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popovi\u0107 ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61(1):77\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"672_CR20","unstructured":"Katia Devorha Menacho Medina, Veronica Culotta, Anish N. Bhuva, Mark Westwood, Leon Menezes, James Moon, Charlotte Manisty. Precision of left ventricular ejection fraction measurement: comparison between 2D and 3D Echocardiography, Nuclear Imaging and Cardiovascular Magnetic Resonance. 22nd Annual SCMR Scientific Sessions; 2019."},{"issue":"23","key":"672_CR21","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/CIRCULATIONAHA.112.100560","volume":"126","author":"MG Khouri","year":"2012","unstructured":"Khouri MG, Douglas PS, Mackey JR, Martin M, Scott JM, Scherrer-Crosbie M, et al. Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. Circulation. 2012;126(23):2749\u201363.","journal-title":"Circulation"},{"issue":"11","key":"672_CR22","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/echo.14152","volume":"35","author":"A Alherbish","year":"2018","unstructured":"Alherbish A, Becher H, Alemayehu W, Paterson DI, Butler CR, Anderson TJ, et al. Impact of contrast echocardiography on accurate discrimination of specific degree of left ventricular systolic dysfunction and comparison with cardiac magnetic resonance imaging. Echocardiography. 2018;35(11):1746\u201354.","journal-title":"Echocardiography"},{"issue":"1","key":"672_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1\u201339.e14.","journal-title":"J Am Soc Echocardiogr"},{"issue":"20","key":"672_CR24","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.jacc.2012.01.037","volume":"59","author":"JL Dorosz","year":"2012","unstructured":"Dorosz JL, Lezotte DC, Weitzenkamp DA, Allen LA, Salcedo EE. Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis. J Am Coll Cardiol. 2012;59(20):1799\u2013808.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"672_CR25","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCULATIONAHA.106.626143","volume":"114","author":"L Sugeng","year":"2006","unstructured":"Sugeng L, Mor-Avi V, Weinert L, Niel J, Ebner C, Steringer-Mascherbauer R, et al. Quantitative assessment of left ventricular size and function: side-by-side comparison of real-time three-dimensional echocardiography and computed tomography with magnetic resonance reference. Circulation. 2006;114(7):654\u201361.","journal-title":"Circulation"},{"issue":"11","key":"672_CR26","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.jacc.2004.01.037","volume":"43","author":"HP K\u00fchl","year":"2004","unstructured":"K\u00fchl HP, Schreckenberg M, Rulands D, Katoh M, Sch\u00e4fer W, Schummers G, et al. High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. J Am Coll Cardiol. 2004;43(11):2083\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"672_CR27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jacc.2004.05.050","volume":"44","author":"C Jenkins","year":"2004","unstructured":"Jenkins C, Bricknell K, Hanekom L, Marwick TH. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol. 2004;44(4):878\u201386.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"672_CR28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/ehjci\/jex033","volume":"18","author":"C Santoro","year":"2017","unstructured":"Santoro C, Arpino G, Esposito R, Lembo M, Paciolla I, Cardalesi C, et al. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility. Eur Heart J Cardiovasc Imaging. 2017;18(8):930\u20136.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"21","key":"672_CR29","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1200\/JCO.2009.26.7294","volume":"28","author":"J Walker","year":"2010","unstructured":"Walker J, Bhullar N, Fallah-Rad N, Lytwyn M, Golian M, Fang T, et al. Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. J Clin Oncol. 2010;28(21):3429\u201336.","journal-title":"J Clin Oncol"},{"issue":"10","key":"672_CR30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9149(97)89179-5","volume":"77","author":"N van Royen","year":"1996","unstructured":"van Royen N, Jaffe CC, Krumholz HM, Johnson KM, Lynch PJ, Natale D, et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol. 1996;77(10):843\u201350.","journal-title":"Am J Cardiol"},{"issue":"1","key":"672_CR31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12968-017-0348-4","volume":"19","author":"H Huang","year":"2017","unstructured":"Huang H, Nijjar PS, Misialek JR, Blaes A, Derrico NP, Kazmirczak F, et al. Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2017;19(1):34.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3\u20134","key":"672_CR32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10554-005-9031-1","volume":"22","author":"M Hacker","year":"2006","unstructured":"Hacker M, Hoyer X, Kupzyk S, La Fougere C, Kois J, Stempfle H-U, et al. Clinical validation of the gated blood pool SPECT QBS processing software in congestive heart failure patients: correlation with MUGA, first-pass RNV and 2D-echocardiography. Int J Card Imaging. 2006;22(3\u20134):407\u201316.","journal-title":"Int J Card Imaging"},{"issue":"6","key":"672_CR33","first-page":"806","volume":"43","author":"K Rajappan","year":"2002","unstructured":"Rajappan K, Livieratos L, Camici PG, Pennell DJ. Measurement of ventricular volumes and function: a comparison of gated PET and cardiovascular magnetic resonance. J Nucl Med. 2002;43(6):806\u201310.","journal-title":"J Nucl Med"},{"key":"672_CR34","doi-asserted-by":"crossref","unstructured":"Petersen SE, Aung N, Sanghvi MM, Zemrak F, Fung K, Paiva JM, et al. Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort. J Cardiovasc Magn Reson. 2017 [cited 2018 Nov 21];19. Available from: \n                      https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5304550\/\n                      \n                    .","DOI":"10.1186\/s12968-017-0327-9"},{"issue":"1049","key":"672_CR35","doi-asserted-by":"crossref","first-page":"20140831","DOI":"10.1259\/bjr.20140831","volume":"88","author":"WE Moody","year":"2015","unstructured":"Moody WE, Edwards NC, Chue CD, Taylor RJ, Ferro CJ, Townend JN, et al. Variability in cardiac MR measurement of left ventricular ejection fraction, volumes and mass in healthy adults: defining a significant change at 1 year. Br J Radiol. 2015;88(1049):20140831.","journal-title":"Br J Radiol"},{"issue":"1","key":"672_CR36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","volume":"90","author":"F Grothues","year":"2002","unstructured":"Grothues F, Smith GC, Moon JCC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29\u201334.","journal-title":"Am J Cardiol"},{"issue":"8","key":"672_CR37","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","volume":"6","author":"BC Drafts","year":"2013","unstructured":"Drafts BC, Twomley KM, D\u2019Agostino R, Lawrence J, Avis N, Ellis LR, et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013;6(8):877\u201385.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"21","key":"672_CR38","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","volume":"37","author":"G Gulati","year":"2016","unstructured":"Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, et al. Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 \u00d7 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol. Eur Heart J. 2016;37(21):1671\u201380.","journal-title":"Eur Heart J"},{"issue":"8","key":"672_CR39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1200\/JCO.2016.68.7830","volume":"35","author":"E Pituskin","year":"2017","unstructured":"Pituskin E, Mackey JR, Koshman S, Jassal D, Pitz M, Haykowsky MJ, et al. Multidisciplinary approach to novel therapies in cardio-oncology research (MANTICORE 101-Breast): a randomized trial for the prevention of trastuzumab-associated cardiotoxicity. J Clin Oncol. 2017;35(8):870\u20137.","journal-title":"J Clin Oncol"},{"issue":"11","key":"672_CR40","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.amjcard.2012.07.040","volume":"110","author":"TG Neilan","year":"2012","unstructured":"Neilan TG, Coelho-Filho OR, Pena-Herrera D, Shah RV, Jerosch-Herold M, Francis SA, et al. Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines. Am J Cardiol. 2012;110(11):1679\u201386.","journal-title":"Am J Cardiol"},{"key":"672_CR41","doi-asserted-by":"crossref","unstructured":"Menacho K, Ramirez S, Segura P, Nordin S, Abdel-Gadir A, Illatopa V, et al. INCA (Peru) study: impact of non-invasive cardiac magnetic resonance assessment in the developing world. J Am Heart Assoc [Internet]. 2018 [cited 2019 Apr 25];7(17). Available from: \n                      https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6201420\/\n                      \n                    .","DOI":"10.1161\/JAHA.118.008981"},{"issue":"15","key":"672_CR42","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","volume":"342","author":"GM Felker","year":"2000","unstructured":"Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077\u201384.","journal-title":"N Engl J Med"},{"issue":"3","key":"672_CR43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","volume":"55","author":"D Cardinale","year":"2010","unstructured":"Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, De Giacomi G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55(3):213\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"672_CR44","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981\u20138.","journal-title":"Circulation"},{"issue":"2","key":"672_CR45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1200\/JCO.1984.2.2.112","volume":"2","author":"MS Ewer","year":"1984","unstructured":"Ewer MS, Ali MK, Mackay B, Wallace S, Valdivieso M, Legha SS, et al. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol. 1984;2(2):112\u20137.","journal-title":"J Clin Oncol"},{"issue":"15","key":"672_CR46","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/eurheartj\/ehl013","volume":"27","author":"TG Neilan","year":"2006","unstructured":"Neilan TG, Jassal DS, Perez-Sanz TM, Raher MJ, Pradhan AD, Buys ES, et al. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J. 2006;27(15):1868\u201375.","journal-title":"Eur Heart J"},{"issue":"1","key":"672_CR47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0735-1097(92)90138-D","volume":"20","author":"MF Stoddard","year":"1992","unstructured":"Stoddard MF, Seeger J, Liddell NE, Hadley TJ, Sullivan DM, Kupersmith J. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol. 1992;20(1):62\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"672_CR48","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/hrt.2003.027516","volume":"90","author":"I Dorup","year":"2004","unstructured":"Dorup I, Levitt G, Sullivan I, Sorensen K. Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function. Heart. 2004;90(10):1214\u20136.","journal-title":"Heart"},{"key":"672_CR49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/IJWH.S68745","volume":"7","author":"AA Kirkham","year":"2015","unstructured":"Kirkham AA, Virani SA, Campbell KL. The utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review. Int J Women's Health. 2015;7:127\u201340.","journal-title":"Int J Women's Health"},{"issue":"6","key":"672_CR50","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/pbc.21289","volume":"49","author":"M Jarfelt","year":"2007","unstructured":"Jarfelt M, Kujacic V, Holmgren D, Bjarnason R, Lannering B. Exercise echocardiography reveals subclinical cardiac dysfunction in young adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2007;49(6):835\u201340.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"672_CR51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2005.07.029","volume":"111","author":"M Civelli","year":"2006","unstructured":"Civelli M, Cardinale D, Martinoni A, Lamantia G, Colombo N, Colombo A, et al. Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity. Int J Cardiol. 2006;111(1):120\u20136.","journal-title":"Int J Cardiol"},{"issue":"4","key":"672_CR52","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1525-2167(03)00017-9","volume":"4","author":"M Bountioukos","year":"2003","unstructured":"Bountioukos M, Doorduijn JK, Roelandt JRTC, Vourvouri EC, Bax JJ, Schinkel AFL, et al. Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity. Eur J Echocardiogr. 2003;4(4):300\u20135.","journal-title":"Eur J Echocardiogr"},{"issue":"25 Pt A","key":"672_CR53","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, Poulin F, Lim K-D, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25 Pt A):2751\u201368.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"672_CR54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.echo.2012.04.007","volume":"25","author":"JT Poterucha","year":"2012","unstructured":"Poterucha JT, Kutty S, Lindquist RK, Li L, Eidem BW. Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr. 2012;25(7):733\u201340.","journal-title":"J Am Soc Echocardiogr"},{"issue":"16","key":"672_CR55","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.ejca.2013.06.046","volume":"49","author":"PW Stoodley","year":"2013","unstructured":"Stoodley PW, Richards DAB, Boyd A, Hui R, Harnett PR, Meikle SR, et al. Left ventricular systolic function in HER2\/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months. Eur J Cancer. 2013;49(16):3396\u2013403.","journal-title":"Eur J Cancer"},{"issue":"3","key":"672_CR56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/echo.14252","volume":"36","author":"Y Anqi","year":"2019","unstructured":"Anqi Y, Yu Z, Mingjun X, Xiaoli K, Mengmeng L, Fangfang L, et al. Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy. Echocardiography. 2019;36(3):495\u2013502.","journal-title":"Echocardiography"},{"issue":"8","key":"672_CR57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1139\/cjpp-2012-0398","volume":"91","author":"C Morno\u015f","year":"2013","unstructured":"Morno\u015f C, Petrescu L. Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist. Can J Physiol Pharmacol. 2013;91(8):601\u20137.","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"672_CR58","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","volume":"5","author":"H Sawaya","year":"2012","unstructured":"Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012;5(5):596\u2013603.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"22","key":"672_CR59","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"N Fallah-Rad","year":"2011","unstructured":"Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T, et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol. 2011;57(22):2263\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"672_CR60","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10554-017-1082-6","volume":"33","author":"F-Y Song","year":"2017","unstructured":"Song F-Y, Shi J, Guo Y, Zhang C-J, Xu Y-C, Zhang Q-L, et al. Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy. Int J Card Imaging. 2017;33(6):857\u201368.","journal-title":"Int J Card Imaging"},{"issue":"8","key":"672_CR61","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jcmg.2018.01.015","volume":"11","author":"KW Zhang","year":"2018","unstructured":"Zhang KW, Finkelman BS, Gulati G, Narayan HK, Upshaw J, Narayan V, et al. Abnormalities in 3-dimensional left ventricular mechanics with anthracycline chemotherapy are associated with systolic and diastolic dysfunction. JACC Cardiovasc Imaging. 2018;11(8):1059\u201368.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"672_CR62","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jcmg.2018.03.019","volume":"11","author":"T Negishi","year":"2018","unstructured":"Negishi T, Thavendiranathan P, Negishi K, Marwick TH. SUCCOUR investigators. Rationale and design of the strain surveillance of chemotherapy for improving cardiovascular outcomes: The SUCCOUR Trial. JACC Cardiovasc Imaging. 2018;11(8):1098\u2013105.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"672_CR63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10741-017-9621-8","volume":"22","author":"A Scatteia","year":"2017","unstructured":"Scatteia A, Baritussio A, Bucciarelli-Ducci C. Strain imaging using cardiac magnetic resonance. Heart Fail Rev. 2017;22(4):465\u201376.","journal-title":"Heart Fail Rev"},{"issue":"23","key":"672_CR64","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/CIRCULATIONAHA.117.027740","volume":"135","author":"S Romano","year":"2017","unstructured":"Romano S, Judd RM, Kim RJ, Kim HW, Klem I, Heitner J, et al. Association of feature-tracking cardiac magnetic resonance imaging left ventricular global longitudinal strain with all-cause mortality in patients with reduced left ventricular ejection fraction. Circulation. 2017;135(23):2313\u20135.","journal-title":"Circulation"},{"issue":"3","key":"672_CR65","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5603\/CJ.a2016.0023","volume":"23","author":"S Nakano","year":"2016","unstructured":"Nakano S, Takahashi M, Kimura F, Senoo T, Saeki T, Ueda S, et al. Cardiac magnetic resonance imaging-based myocardial strain study for evaluation of cardiotoxicity in breast cancer patients treated with trastuzumab: a pilot study to evaluate the feasibility of the method. Cardiol J. 2016;23(3):270\u201380.","journal-title":"Cardiol J"},{"issue":"4","key":"672_CR66","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/COC.0b013e31829e19be","volume":"38","author":"Matthew A. Lunning","year":"2015","unstructured":"Lunning MA, Kutty S, Rome ET, Li L, Padiyath A, Loberiza F, et al. Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy. Am J Clin Oncol. 2015;38(4):377-81.","journal-title":"American Journal of Clinical Oncology"},{"key":"672_CR67","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2018.03.041","volume":"261","author":"G Ong","year":"2018","unstructured":"Ong G, Brezden-Masley C, Dhir V, Deva DP, Chan KKW, Chow C-M, et al. Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy. Int J Cardiol. 2018;261:228\u201333.","journal-title":"Int J Cardiol"},{"issue":"7","key":"672_CR68","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cjca.2016.01.027","volume":"32","author":"R Moudgil","year":"2016","unstructured":"Moudgil R, Yeh ETH. Mechanisms of cardiotoxicity of cancer chemotherapeutic agents: cardiomyopathy and beyond. Can J Cardiol. 2016;32(7):863\u2013870.e5.","journal-title":"Can J Cardiol"},{"issue":"5","key":"672_CR69","doi-asserted-by":"crossref","first-page":"H1956","DOI":"10.1152\/ajpheart.00407.2008","volume":"295","author":"J Liu","year":"2008","unstructured":"Liu J, Mao W, Ding B, Liang C. ERKs\/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am J Physiol Heart Circ Physiol. 2008;295(5):H1956\u201365.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"672_CR70","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1634\/theoncologist.2018-0157","volume":"23","author":"TG Neilan","year":"2018","unstructured":"Neilan TG, Rothenberg ML, Amiri-Kordestani L, Sullivan RJ, Steingart RM, Gregory W, et al. Myocarditis associated with immune checkpoint inhibitors: an expert consensus on data gaps and a call to action. Oncologist. 2018;23(8):874\u20138.","journal-title":"Oncologist."},{"issue":"1","key":"672_CR71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00432-007-0250-9","volume":"134","author":"C Kosmas","year":"2008","unstructured":"Kosmas C, Kallistratos MS, Kopterides P, Syrios J, Skopelitis H, Mylonakis N, et al. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res Clin Oncol. 2008;134(1):75\u201382.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"672_CR72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11912-018-0690-1","volume":"20","author":"A Asnani","year":"2018","unstructured":"Asnani A. Cardiotoxicity of immunotherapy: incidence, diagnosis, and management. Curr Oncol Rep. 2018;20(6):44.","journal-title":"Curr Oncol Rep"},{"key":"672_CR73","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.lungcan.2017.07.028","volume":"114","author":"E Liu","year":"2017","unstructured":"Liu E, Guha A, Jia K, Ayers AM, Boudoulas KD, Bertino E, et al. Cardiogenic shock in a patient being treated with atezolizumab for metastatic non-small cell lung cancer. Lung Cancer. 2017;114:106\u20137.","journal-title":"Lung Cancer"},{"issue":"23","key":"672_CR74","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/CIRCULATIONAHA.105.570648","volume":"113","author":"RY Kwong","year":"2006","unstructured":"Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113(23):2733\u201343.","journal-title":"Circulation"},{"issue":"11","key":"672_CR75","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","volume":"56","author":"R O\u2019Hanlon","year":"2010","unstructured":"O\u2019Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56(11):867\u201374.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"672_CR76","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCIMAGING.109.918540","volume":"3","author":"JC Lightfoot","year":"2010","unstructured":"Lightfoot JC, D\u2019Agostino RB, Hamilton CA, Jordan J, Torti FM, Kock ND, et al. Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model. Circ Cardiovasc Imaging. 2010;3(5):550\u20138.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"672_CR77","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/CIRCIMAGING.113.000899","volume":"6","author":"P Thavendiranathan","year":"2013","unstructured":"Thavendiranathan P, Wintersperger BJ, Flamm SD, Marwick TH. Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review. Circ Cardiovasc Imaging. 2013;6(6):1080\u201391.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"20","key":"672_CR78","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.jacc.2017.03.560","volume":"69","author":"V Maestrini","year":"2017","unstructured":"Maestrini V, Cheang MH, Kotwinski P, Rosmini S, Lloyd G, Kellman P, et al. Late anthracycline-related cardiotoxicity in low-risk breast cancer patients. J Am Coll Cardiol. 2017;69(20):2573\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"672_CR79","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcmg.2017.04.006","volume":"11","author":"S Nakamori","year":"2018","unstructured":"Nakamori S, Dohi K, Ishida M, Goto Y, Imanaka-Yoshida K, Omori T, et al. Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging. 2018;11(1):48\u201359.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"672_CR80","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.109.930636","volume":"122","author":"AS Flett","year":"2010","unstructured":"Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122(2):138\u201344.","journal-title":"Circulation"},{"key":"672_CR81","doi-asserted-by":"crossref","unstructured":"Jordan JH, Vasu S, Morgan TM, D\u2019Agostino RB, Mel\u00e9ndez GC, Hamilton CA, et al. Anthracycline-associated T1 mapping characteristics are elevated independent of the presence of cardiovascular comorbidities in cancer survivors. Circ Cardiovasc Imaging. 2016;9(8).","DOI":"10.1161\/CIRCIMAGING.115.004325"},{"issue":"5","key":"672_CR82","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amjcard.2012.11.022","volume":"111","author":"TG Neilan","year":"2013","unstructured":"Neilan TG, Coelho-Filho OR, Shah RV, Feng JH, Pena-Herrera D, Mandry D, et al. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol. 2013;111(5):717\u201322.","journal-title":"Am J Cardiol"},{"key":"672_CR83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2018.03.025","volume":"261","author":"A Kimball","year":"2018","unstructured":"Kimball A, Patil S, Koczwara B, Raman KS, Perry R, Grover S, et al. Late characterisation of cardiac effects following anthracycline and trastuzumab treatment in breast cancer patients. Int J Cardiol. 2018;261:159\u201361.","journal-title":"Int J Cardiol"},{"issue":"7","key":"672_CR84","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2018.11.046","volume":"73","author":"C Gal\u00e1n-Arriola","year":"2019","unstructured":"\u2022 Gal\u00e1n-Arriola C, Lobo M, V\u00edlchez-Tschischke JP, L\u00f3pez GJ, de Molina-Iracheta A, P\u00e9rez-Mart\u00ednez C, et al. Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity. J Am Coll Cardiol. 2019;73(7):779\u201391 Study in a large animal model showing that T2 mapping abnormalities provide the earliest marker of subtle myocardial damage following anthracycline treatment, with T2 relaxation times prolonged long before LV motion abnormalities are detected.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"672_CR85","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","volume":"71","author":"SS Mahmood","year":"2018","unstructured":"Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling LM, et al. Myocarditis in patients treated with immune checkpoint inhibitors. J Am Coll Cardiol. 2018;71(16):1755\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"672_CR86","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12350-016-0616-y","volume":"25","author":"F Nensa","year":"2018","unstructured":"Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, et al. Feasibility of FDG-PET in myocarditis: comparison to CMR using integrated PET\/MRI. J Nucl Cardiol. 2018;25(3):785\u201394.","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"672_CR87","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4329\/wjr.v4.i5.220","volume":"4","author":"C Borde","year":"2012","unstructured":"Borde C, Kand P, Basu S. Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: evidence of early chemotherapeutic cardiotoxicity? World J Radiol. 2012;4(5):220\u20133.","journal-title":"World J Radiol"},{"issue":"10","key":"672_CR88","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.117.191122","volume":"58","author":"M Bauckneht","year":"2017","unstructured":"Bauckneht M, Ferrarazzo G, Fiz F, Morbelli S, Sarocchi M, Pastorino F, et al. Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: a translational 18F-FDG PET\/CT observation. J Nucl Med. 2017;58(10):1638\u201345.","journal-title":"J Nucl Med"},{"issue":"1","key":"672_CR89","first-page":"8","volume":"1","author":"DK Shakir","year":"2009","unstructured":"Shakir DK, Rasul KI. Chemotherapy induced cardiomyopathy: pathogenesis, monitoring and management. J Clin Med Res. 2009;1(1):8\u201312.","journal-title":"J Clin Med Res"},{"issue":"1","key":"672_CR90","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12968-017-0356-4","volume":"19","author":"A Barthur","year":"2017","unstructured":"Barthur A, Brezden-Masley C, Connelly KA, Dhir V, Chan KKW, Haq R, et al. Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study. J Cardiovasc Magn Reson. 2017;19(1):44.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"7","key":"672_CR91","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/clc.22672","volume":"40","author":"M Tadic","year":"2017","unstructured":"Tadic M, Cuspidi C, Hering D, Venneri L, Danylenko O. The influence of chemotherapy on the right ventricle: did we forget something? Clin Cardiol. 2017;40(7):437\u201343.","journal-title":"Clin Cardiol"},{"issue":"5","key":"672_CR92","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.acvd.2013.02.003","volume":"106","author":"M Andrejak","year":"2013","unstructured":"Andrejak M, Tribouilloy C. Drug-induced valvular heart disease: an update. Arch Cardiovasc Dis. 2013;106(5):333\u20139.","journal-title":"Arch Cardiovasc Dis"},{"issue":"3","key":"672_CR93","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcmg.2015.06.028","volume":"9","author":"K Murbraech","year":"2016","unstructured":"Murbraech K, Wethal T, Smeland KB, Holte H, Loge JH, Holte E, et al. Valvular dysfunction in lymphoma survivors treated with autologous stem cell transplantation: a national cross-sectional study. JACC Cardiovasc Imaging. 2016;9(3):230\u20139.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"672_CR94","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11864-019-0644-3","volume":"20","author":"D Das","year":"2019","unstructured":"Das D, Asher A, Ghosh AK. Cancer and coronary artery disease: common associations, diagnosis and management challenges. Curr Treat Options in Oncol. 2019;20(6):46.","journal-title":"Curr Treat Options in Oncol"},{"issue":"13","key":"672_CR95","first-page":"991","volume":"38","author":"I Danad","year":"2017","unstructured":"Danad I, Szymonifka J, Twisk JWR, Norgaard BL, Zarins CK, Knaapen P, et al. Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis. Eur Heart J. 2017;38(13):991\u20138.","journal-title":"Eur Heart J"},{"key":"672_CR96","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12968-017-0388-9","volume":"19","author":"H Engblom","year":"2017","unstructured":"Engblom H, Xue H, Akil S, Carlsson M, Hindorf C, Oddstig J, et al. Fully quantitative cardiovascular magnetic resonance myocardial perfusion ready for clinical use: a comparison between cardiovascular magnetic resonance imaging and positron emission tomography. J Cardiovasc Magn Reson. 2017;19:78.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"672_CR97","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/heartjnl-2015-308765","volume":"102","author":"DM Gujral","year":"2016","unstructured":"Gujral DM, Lloyd G, Bhattacharyya S. Radiation-induced valvular heart disease. Heart. 2016;102(4):269\u201376.","journal-title":"Heart"},{"key":"672_CR98","doi-asserted-by":"crossref","unstructured":"Donnellan E, Masri A, Johnston DR, Pettersson GB, Rodriguez LL, Popovic ZB, et al. Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study. J Am Heart Assoc. 2017;6(5).","DOI":"10.1161\/JAHA.116.005396"},{"issue":"16","key":"672_CR99","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1161\/CIRCULATIONAHA.118.035514","volume":"138","author":"E Donnellan","year":"2018","unstructured":"Donnellan E, Krishnaswamy A, Hutt-Centeno E, Johnston DR, Aguilera J, Kapadia SR, et al. Outcomes of patients with mediastinal radiation-associated severe aortic stenosis undergoing transcatheter aortic valve replacement. Circulation. 2018;138(16):1752\u20134.","journal-title":"Circulation."},{"issue":"1","key":"672_CR100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5152\/dir.2014.14239","volume":"21","author":"M Dursun","year":"2015","unstructured":"Dursun M, Y\u0131lmaz S, Y\u0131lmaz E, Y\u0131lmaz R, Onur \u0130, Oflaz H, et al. The utility of cardiac MRI in diagnosis of infective endocarditis: preliminary results. Diagn Interv Radiol. 2015;21(1):28\u201333.","journal-title":"Diagn Interv Radiol"},{"issue":"2","key":"672_CR101","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/ehjci\/jex010","volume":"19","author":"HJ Koo","year":"2018","unstructured":"Koo HJ, Yang DH, Kang J-W, Lee JY, Kim D-H, Song J-M, et al. Demonstration of infective endocarditis by cardiac CT and transoesophageal echocardiography: comparison with intra-operative findings. Eur Heart J Cardiovasc Imaging. 2018;19(2):199\u2013207.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"14","key":"672_CR102","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.118.035032","volume":"138","author":"LE Swart","year":"2018","unstructured":"Swart LE, Gomes A, Scholtens AM, Sinha B, Tanis W, Lam MGEH, et al. Improving the diagnostic performance of 18F-fluorodeoxyglucose positron-emission tomography\/computed tomography in prosthetic heart valve endocarditis. Circulation. 2018;138(14):1412\u201327.","journal-title":"Circulation."},{"issue":"22","key":"672_CR103","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","volume":"63","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):2438\u201388.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"672_CR104","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11936-018-0654-7","volume":"20","author":"AK Ghosh","year":"2018","unstructured":"Ghosh AK, Crake T, Manisty C, Westwood M. Pericardial disease in cancer patients. Curr Treat Options Cardiovasc Med. 2018;20(7):60.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"672_CR105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1532-429X-11-14","volume":"11","author":"J Bogaert","year":"2009","unstructured":"Bogaert J, Francone M. Cardiovascular magnetic resonance in pericardial diseases. J Cardiovasc Magn Reson. 2009;11:14.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"21","key":"672_CR106","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1182\/blood.V122.21.4017.4017","volume":"122","author":"S-E Lee","year":"2013","unstructured":"Lee S-E, Kim S-H, Choi S-Y, Park J-E, Jeon H-R, Jang E-J, et al. Six-year follow-up of dasatinib-related pulmonary arterial hypertension (PAH) for chronic myeloid leukemia in single center. Blood. 2013;122(21):4017.","journal-title":"Blood."},{"issue":"2","key":"672_CR107","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ajpath.2014.10.021","volume":"185","author":"B Ranchoux","year":"2015","unstructured":"Ranchoux B, G\u00fcnther S, Quarck R, Chaumais M-C, Dorfm\u00fcller P, Antigny F, et al. Chemotherapy-induced pulmonary hypertension: role of alkylating agents. Am J Pathol. 2015;185(2):356\u201371.","journal-title":"Am J Pathol"},{"issue":"12","key":"672_CR108","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/eurheartj\/ehr104","volume":"32","author":"S Fussen","year":"2011","unstructured":"Fussen S, De Boeck BWL, Zellweger MJ, Bremerich J, Goetschalckx K, Zuber M, et al. Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours. Eur Heart J. 2011;32(12):1551\u201360.","journal-title":"Eur Heart J"},{"issue":"1","key":"672_CR109","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1148\/radiol.13121239","volume":"268","author":"M Motwani","year":"2013","unstructured":"Motwani M, Kidambi A, Herzog BA, Uddin A, Greenwood JP, Plein S. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology. 2013;268(1):26\u201343.","journal-title":"Radiology"},{"issue":"9","key":"672_CR110","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jcmg.2014.05.009","volume":"7","author":"P Pazos-L\u00f3pez","year":"2014","unstructured":"Pazos-L\u00f3pez P, Pozo E, Siqueira ME, Garc\u00eda-Lunar I, Cham M, Jacobi A, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc Imaging. 2014;7(9):896\u2013905.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"672_CR111","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2967\/jnumed.111.095364","volume":"53","author":"K Rahbar","year":"2012","unstructured":"Rahbar K, Seifarth H, Sch\u00e4fers M, Stegger L, Hoffmeier A, Spieker T, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET\/CT. J Nucl Med. 2012;53(6):856\u201363.","journal-title":"J Nucl Med"},{"issue":"3","key":"672_CR112","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12574-015-0249-1","volume":"13","author":"F Cacciapuoti","year":"2015","unstructured":"Cacciapuoti F. The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis. J Echocardiogr. 2015;13(3):84\u20139.","journal-title":"J Echocardiogr"},{"issue":"4","key":"672_CR113","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","volume":"36","author":"SM Banypersad","year":"2015","unstructured":"Banypersad SM, Fontana M, Maestrini V, Sado DM, Captur G, Petrie A, et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J. 2015;36(4):244\u201351.","journal-title":"Eur Heart J"},{"issue":"4","key":"672_CR114","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/13506129.2018.1552852","volume":"25","author":"R Manwani","year":"2018","unstructured":"Manwani R, Page J, Lane T, Burniston M, Skillen A, Lachmann HJ, et al. A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement. Amyloid. 2018;25(4):247\u201352.","journal-title":"Amyloid"},{"issue":"1","key":"672_CR115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/med.21463","volume":"38","author":"P-P Zheng","year":"2018","unstructured":"Zheng P-P, Li J, Kros JM. Breakthroughs in modern cancer therapy and elusive cardiotoxicity: critical research-practice gaps, challenges, and insights. Med Res Rev. 2018;38(1):325\u201376.","journal-title":"Med Res Rev"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-019-0672-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-019-0672-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-019-0672-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T23:22:56Z","timestamp":1596756176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-019-0672-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,8]]},"references-count":115,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["672"],"URL":"https:\/\/doi.org\/10.1007\/s11864-019-0672-z","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,8]]},"assertion":[{"value":"8 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"73"}}